Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection
Year: 2022
Type: review
Abstract: Patient-reported outcomes (PROs) are used in clinical trials to provide evidence of the benefits and risks of interventions from a patient perspective and to inform regulatory decisions and health policy. The collection of PROs in routine practice can facilitate monitoring of patient symptoms; identification of unmet needs; prioritisation and/or tailoring of treatment to the needs of individual patients and inform value-based healthcare initiatives. However, respondent burden needs to be carefully considered and addressed to avoid high rates of missing data and poor reporting of PRO results, which may lead to poor quality data for regulatory decision making and/or clinical care.
Source: Nature Communications
Authors: Olalekan Lee Aiyegbusi, Jessica Roydhouse, Samantha Cruz Rivera, Paul Kamudoni, Peter Schache, Roger Wilson, Richard Stephens, Melanie Calvert
Institutions: University Hospitals Birmingham NHS Foundation Trust, National Institute for Health and Care Research, NIHR Birmingham Biomedical Research Centre, University of Birmingham, University of Tasmania, Menzies Institute for Medical Research, Merck KGaA, Darmstadt (Germany), NIHR Surgical Reconstruction and Microbiology Research Centre, Health Data Research UK
Language: English
Subfield: Sociology and Political Science
Field: Social Sciences
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $5,890
Funders: Amgen, GlaxoSmithKline, Gilead Sciences, Patient-Centered Outcomes Research Institute, Sarcoma UK, Macmillan Cancer Support, University Hospitals Birmingham NHS Foundation Trust, UK Research and Innovation, National Institute for Health and Care Research, University of Birmingham, Astellas Pharma, Surgical Reconstruction and Microbiology Research Centre, Innovate UK, European Regional Development Fund, Birmingham Biomedical Research Centre, National Institute for Health Research Applied Research Collaboration West, Janssen Pharmaceuticals, UCB Pharma, Daiichi Sankyo Europe, Health Data Research UK
OpenAlex ID: W4304731581
